In conclusion, levothyroxine tablets combined with iodine-131 for the treatment of thyroid cancer patients undergoing radical thyroidectomy could effectively improve the patients' treatment efficiency, reduce the risk of postoperative cancer recurrence and metastasis, control the patient's serum Tg and TgAb level, and prolong the survival of patients, with a high safety profile. This evidence concerns the gene TG and thyroid cancer.